Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 29;11(11):e053768.
doi: 10.1136/bmjopen-2021-053768.

SARS-CoV-2 and influenza virus coinfection among patients with severe acute respiratory infection during the first wave of COVID-19 pandemic in Bangladesh: a hospital-based descriptive study

Affiliations

SARS-CoV-2 and influenza virus coinfection among patients with severe acute respiratory infection during the first wave of COVID-19 pandemic in Bangladesh: a hospital-based descriptive study

Zubair Akhtar et al. BMJ Open. .

Abstract

Objective: To estimate the proportion of SARS-CoV-2 and influenza virus coinfection among severe acute respiratory infection (SARI) cases-patients during the first wave of COVID-19 pandemic in Bangladesh.

Design: Descriptive study.

Setting: Nine tertiary level hospitals across Bangladesh.

Participants: Patients admitted as SARI (defined as cases with subjective or measured fever of ≥38 C° and cough with onset within the last 10 days and requiring hospital admission) case-patients.

Primary and secondary outcomes: Proportion of SARS-CoV-2 and influenza virus coinfection and proportion of mortality among SARI case-patients.

Results: We enrolled 1986 SARI case-patients with a median age: 28 years (IQR: 1.2-53 years), and 67.6% were male. Among them, 285 (14.3%) were infected with SARS-CoV-2; 175 (8.8%) were infected with the influenza virus, and five (0.3%) were coinfected with both viruses. There was a non-appearance of influenza during the usual peak season (May to July) in Bangladesh. SARS-CoV-2 infection was significantly more associated with diabetes (14.0% vs 5.9%, p<0.001) and hypertension (26.7% vs 11.5%, p<0.001). But influenza among SARI case-patients was significantly less associated with diabetes (4.0% vs 7.4%, p=0.047) and hypertension (5.7% vs 14.4%, p=0.001). The proportion of in-hospital deaths among SARS-CoV-2 infected SARI case-patients were higher (10.9% (n=31) vs 4.4% (n=75), p<0.001) than those without SARS-CoV-2 infection; the proportion of postdischarge deaths within 30 days was also higher (9.1% (n=25) vs 4.6% (n=74), p=0.001) among SARS-CoV-2 infected SARI case-patients than those without infection. No in-hospital mortality or postdischarge mortality was registered among the five coinfected SARI case-patients.

Conclusions: Our findings suggest that coinfection with SARS-CoV-2 and influenza virus was not very common and had less disease severity considering mortality in Bangladesh. There was no circulating influenza virus during the influenza peak season during the COVID-19 pandemic in 2020. Future studies are warranted for further exploration.

Keywords: COVID-19; epidemiology; infectious diseases.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study sites of the hospital-based influenza surveillance system: Public hospitals (1. RMCH: Rajshahi Medical College Hospital, Rajshahi; 2. CuMCH: Cumilla Medical College Hospital, Cumilla; 3. KMCH: Khulna Medical College Hospital, Khulna; 4. SBMCH: Sher-e-Bangla Medical College Hospital, Barishal; 5. CMCH: Chattogram Medical College Hospital, Chattogram; 6. MARMCH: M Abdur Rahim Medical College Hospital, Dinajpur; 7. JGH Jashore 250 bed General Hospital, Jashore) Private hospitals* (1. JIMCH: Jahurul Islam Medical College Hospital, Kishoregonj; 2. JRRMCH: Jalalabad Ragib-Rabeya Medical College Hospital, Sylhet.)
Figure 2
Figure 2
SARS-CoV-2, influenza virus and coinfection during March–December 2020 among SARI case patients in Bangladesh. SARI, severe acute respiratory infection.

Similar articles

Cited by

References

    1. Hampson AW. Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Ann Acad Med Singap 2008;37:510. - PubMed
    1. Tamerius J, Nelson MI, Zhou SZ, et al. . Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ Health Perspect 2011;119:439–45. 10.1289/ehp.1002383 - DOI - PMC - PubMed
    1. Azziz Baumgartner E, Dao CN, Nasreen S, et al. . Seasonality, timing, and climate drivers of influenza activity worldwide. J Infect Dis 2012;206:838–46. 10.1093/infdis/jis467 - DOI - PubMed
    1. Saha S, Chadha M, Al Mamun A, et al. . Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia. Bull World Health Organ 2014;92:318–30. 10.2471/BLT.13.124412 - DOI - PMC - PubMed
    1. Zaman RU, Alamgir ASM, Rahman M, et al. . Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008. PLoS One 2009;4:e8452. 10.1371/journal.pone.0008452 - DOI - PMC - PubMed

Publication types